dacarbazine has been researched along with Canine Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, D; Morandi, L; Nytko, KJ; Rohrer Bley, C; Tonon, C; Tresch, NS | 1 |
| Fuchs, D; Morandi, L; Nytko, KJ; Rohrer Bley, C; Tonon, C; Weyland, MS | 1 |
| Barber, LG; Jennings, SH; Kezer, KA | 1 |
| Bianchi, C; Carrara, N; Dolera, M; Finesso, S; Malfassi, L; Marcarini, S; Mazza, G; Pavesi, S; Sala, M; Urso, G | 1 |
| Baines, SJ; Blackwood, L; Elliott, JW; Treggiari, E | 1 |
| Bernal, G; Larsen, GF; Mansour, N; Nunez, L; Podell, M; Polster, SP; Yamini, B; Young, JS | 1 |
| Agnoli, C; Amati, M; Annoni, M; Capitani, O; Chalfon, C; Finotello, R; Marconato, L; Mesto, P; Polton, G; Sabattini, S; Stefanello, D; Vasconi, ME | 1 |
| Aresu, L; Cancedda, S; Dacasto, M; Gracis, M; Leone, VF; Marconato, L; Pizzoni, S; Rohrer Bley, C | 1 |
| Finotello, R; Marconato, L; Stefanello, D; Zini, E | 1 |
| Cicchelero, L; Daminet, S; de Rooster, H; Denies, S; Polis, I; Sanders, NN; Van de Maele, I | 1 |
| Cadile, CD; Dervisis, NG; Dominguez, PA; Kitchell, BE; Newman, RG; Sarbu, L; Swanson, CN | 1 |
| Gleiser, CA; Gray, KN; Jardine, JH; Raulston, GL | 1 |
| Goitsuka, R; Goto, N; Hasegawa, A; Momoi, Y; Ono, K; Shimada, T; Tsujimoto, H; Uno, Y; Watari, T | 1 |
3 trial(s) available for dacarbazine and Canine Diseases
| Article | Year |
|---|---|
Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors.
Topics: Animals; Antineoplastic Agents; Brain; Convection; Dacarbazine; Dog Diseases; Dogs; Drug Delivery Systems; Female; Glioma; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Nanoparticles; Pilot Projects; Polymers; Supratentorial Neoplasms; Temozolomide; Treatment Outcome; Tumor Burden | 2018 |
Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Dog Diseases; Dogs; Melanoma; Radiotherapy; Temozolomide | 2016 |
Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma.
Topics: Animals; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dog Diseases; Dogs; Drug Resistance, Neoplasm; Female; Lymphoma; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Temozolomide; Time Factors; Treatment Outcome | 2007 |
10 other study(ies) available for dacarbazine and Canine Diseases
| Article | Year |
|---|---|
Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines.
Topics: Animals; Brain Neoplasms; Cell Line; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Dog Diseases; Dogs; Glioma; Humans; Temozolomide; Tumor Suppressor Proteins | 2021 |
Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro.
Topics: Animals; Cell Survival; Dacarbazine; Dog Diseases; Dogs; Glioma; Lomustine; Temozolomide | 2023 |
Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.
Topics: Animals; Antineoplastic Agents, Alkylating; Dacarbazine; Dog Diseases; Dogs; Female; Histiocytic Sarcoma; Male; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2018 |
Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Dog Diseases; Dogs; Female; Glioma; Male; Radiosurgery; Survival Analysis; Temozolomide | 2018 |
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Databases, Factual; Dog Diseases; Dogs; Doxorubicin; Kaplan-Meier Estimate; Lymphoma; Recurrence; Retrospective Studies; Survival; Temozolomide; Treatment Outcome; United Kingdom | 2018 |
Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Topics: Administration, Metronomic; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Dog Diseases; Dogs; Doxorubicin; Female; Hemangiosarcoma; Male; Retrospective Studies; Splenic Neoplasms; Treatment Outcome; Vincristine | 2019 |
Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Cyclophosphamide; Dacarbazine; Dog Diseases; Dogs; Doxorubicin; Female; Hemangiosarcoma; Male; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome | 2017 |
Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patients.
Topics: Administration, Metronomic; Animals; Antineoplastic Agents, Alkylating; Case-Control Studies; Cyclophosphamide; Dacarbazine; Dog Diseases; Dogs; Lymphocyte Count; Neoplasms; T-Lymphocytes, Regulatory; Temozolomide; Thrombospondin 1; Vascular Endothelial Growth Factor A | 2017 |
Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dog Diseases; Dogs; Doxorubicin; Female; Lymphoma; Male; Prognosis | 1984 |
Malignant histiocytosis with multiple skin lesions in a dog.
Topics: Animals; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dog Diseases; Dogs; Heart Neoplasms; Histiocytic Sarcoma; Male; Mitoxantrone; Muscles; Myocardium; Prednisolone; Skin; Skin Neoplasms; Vincristine | 1993 |